Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...
Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) were sinking 8.2% lower as of 10:57 a.m. ET on Monday. The clinical-stage ...
The latest price target for Recursion Pharmaceuticals (NASDAQ:RXRX) was reported by JP Morgan on December 17, 2025. The analyst firm set a price target for $11.00 expecting RXRX to rise to within 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback